Insilico Medicine Reports Growing Revenue from AI Drug Discovery Partnerships

CEO Alex Zhavoronkov highlighted the company's increasing financial returns from collaborations with other AI firms during a Bloomberg interview focusing on their drug discovery business outlook.

27 Aug, 04:29 — 27 Aug, 04:29

Post Share

Sources

Showing 1 of 1 sources

bloombergHigh5d ago

Insilico Sees Rising Revenue From Deals With AI Firms

Alex Zhavoronkov, Founder & CEO at Insilico Medicine, discusses the AI-drug discovery firm's earnings and business outlook exclusively on "Bloomberg: The China Show." (Source: Bloomberg)

Read full article →

Insilico Medicine Reports Growing Revenue from AI Drug Discovery Partnerships

Sources

Insilico Sees Rising Revenue From Deals With AI Firms

Related Stories

China's Solar Power Capacity Overtakes Coal for First Time

Anthropic Signs $35 Billion Cloud Computing Deal With Lambda

Romania Launches New Digital Health Portal for Patient Appointments

Trump Presses Apple to Rename Lake Ontario as Lake America